All articles tagged with #fecal transplant
Early exploratory results hint that altering gut bacteria through fecal microbiota transplantation might influence bipolar disorder symptoms, after initial anecdotes that antibiotics helped two patients; researchers at the University of Calgary are examining the gut–brain link, but any therapeutic potential remains unproven pending larger, controlled trials.
Researchers mapped the gut microbes and metabolic pathways that can produce ethanol in auto-brewery syndrome (ABS), implicating bacteria such as E. coli and Klebsiella pneumoniae and showing elevated ethanol production during ABS flares; these insights could lead to stool-based diagnostics and microbiome-targeted therapies, including fecal transplantation, which in one patient kept symptoms at bay for over 16 months.
A new study in Nature shows that maintaining a healthy diet is more effective than fecal transplants in restoring and protecting the gut microbiome, emphasizing the importance of diet in microbiome recovery and pathogen defense.
A small clinical trial suggests that fecal transplants from healthy donors could improve motor symptoms in early-stage Parkinson's disease patients. The study found that recipients of the transplants showed significant improvements in motor symptoms and constipation, but also experienced increased fatigue. Experts believe that the gut microbiome may play a role in neurodegenerative conditions, and further research is needed to understand the potential of fecal transplants as a treatment option for Parkinson's disease.
A recent clinical trial has shown that fecal microbiota transplants (FMTs) from healthy donors into early stage Parkinson's patients led to mild but significant improvement in motoric symptoms over the course of a year, suggesting a potential new treatment for Parkinson's disease. The research team from Belgium administered the fecal transplants through the noses of the patients, with participants showing improvements in motor scores and slower development of constipation. While more research is needed, this study offers promising hints that FMT could be a valuable new treatment for Parkinson's disease, potentially leading to the development of a bacterial pill or other targeted therapy in the future.
Jamie Rettinger, who was diagnosed with melanoma, underwent a fecal transplant (FMT) as part of a clinical trial at the UPMC Hillman Cancer Center in Pittsburgh. The trial aimed to improve the cure rate of patients who did not respond to immunotherapies for melanoma. The FMT engrafted and the once-missing bacteria were thriving in his gut, and his body responded to another monoclonal antibody, and signs of melanoma began to shrink. Six of 15 patients responded positively in the pilot clinical trial.